Ltd. Research Institute Branch Company;Tianjin Zhongxin Pharmaceutical Group Corp.
发明人:
申请号：
EP18812748.4
公开号：
EP3636628A1
申请日:
2018.06.07
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to a derivative of 13-oxidized ingenol, use thereof in the prevention and/or treatment of a disease associated with proliferation or tumor in a subject, or a cosmetic indication, and use thereof in the prevention and/or treatment of a disease responsive to neutrophil oxidative burst, a disease responsive to a release of IL-8 by keratinocyte, or a disease responsive to induction of necrosis.
